| News

Axtria driving growth from Basel

01.02.2021

The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry in the field of cloud software and data analysis. Axtria is now planning to exploit the wealth of talent and specialists in the Basel Area to drive further growth.

Jaswinder Chadha, Co-Founder and CEO of Axtria (img: Axtria)

Founded in 2010, Axtria works with the 20 leading international life sciences firms, according to information from the company itself. Headquartered in the US state of New Jersey with a stronghold in India, the provider of cloud software and data analysis solutions aims to make decision-making processes easier for its clients by offering them the tools necessary for targeted research data analysis. To provide these services, Axtria relies on well-trained employees. This is just one of the reasons why the company has now decided on Basel as a new location. Basel Area Business & Innovation, the investment and innovation promotion agency, supported Axtria during the process of founding Axtria Swiss GmbH.

Axtria presently employs around 2,000 members of staff across the world. Of this number, 800 were only hired in 2020 alone. At the company headquarters in New Jersey, Axtria has been listed as one of the state’s 50 fastest-growing companies for seven successive years. “We are proud of our substantial growth within the market, and our investments within the company reflect our commitment to continue that progress”, comments Jaswinder Chadha, co-founder and CEO of Axtria. Chadha goes on to describe Europe and the USA as the company’s most important markets. With the opening of new offices, Axtria employees will be in a position to “make an impact in the life sciences industry”.

In this context, the company also underlines that its Basel office is part of a long-term corporate strategy that aims to operate in close proximity to its customers. Basel is, after all, home to numerous companies active in the field of life sciences. Moreover, Axtria’s growth will be advanced by well-trained employees. For this reason, Basel is a prime location for the company from which it can implement plans to drive both sales and therefore growth as well.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Bottmedical enters the market with innovative braces
Basel Area Business & Innovation, Innovation, Invest

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

Read More
TargImmune raises nearly 18 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

Read More
KetoSwiss launches first product in the USA
Basel Area Business & Innovation, Innovation, Invest

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Read More
For Swiss startups, China might be closer than it seems
Basel Area Business & Innovation, Invest

For Swiss startups, China might be closer than it seems

China wants to strengthen domestic demand and be less dependent on imports. This policy has huge implications for the life...

Read More
Basel Area treads unique path
Basel Area Business & Innovation, Innovation, Invest

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Read More
Alentis secures 67 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

Read More
1 2 3 46

Do you have a question? We'd like to hear from you.